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Background: Transitions between different levels of healthcare, such as hospital admission and discharge, pose a
considerable threat to the quality and continuity of drug therapy. This study aims to further explore the current role
of hospitalization in prescribing error exposure and medication-related communication as patients are transferred
from and back to ambulatory care.
Methods: Assisted by electronic decision support, pre-admission and discharge medication regimens of 187 adult
patients in a German university hospital were comparatively screened for clinically relevant categories of potentially
inadequate prescribing. Binary logistic regression analyses were conducted to identify risk factors predisposing individuals
to prescribing errors as a result of hospitalization. Additionally, it was established to what extent medication changes
and potentially inappropriate prescribing decisions originating from inpatient treatment were communicated in
discharge letters.
Results: 94.7% of the patients are subjected to differences between pre-admission and discharge prescriptions
occurring at a rate of 461 per 100 hospitalizations. However, these modifications in drug therapy do not have a
significant effect on the total number of potential prescribing errors per patient (p = 0.135) even though a large
potential for improvement exists throughout the care continuum. For instance, almost a quarter of study participants
with impaired kidney function lacks appropriate dose adjustment for one or more drugs before onset and at the end
of inpatient treatment alike (22.5% [95% CI: 13.5%-34.0%] vs. 22.8% [95% CI: 14.1%-33.6%]). Overall, the probability of
error exposure following hospitalization rises with an increasing number of prescribed drugs per patient, while
individuals treated on surgical wards are four times more likely to be discharged with a prescribing-related safety
hazard than their counterparts from medical departments (OR: 4.069 [95% CI: 1.126-14.703]; p = 0.032). In the
study population’s discharge summaries only 14.8% of medication changes and none of the potentially inappropriate
prescribing decisions made during inpatient care are addressed, despite the latter occurring at a rate of 91 per 100
hospitalizations.
Conclusions: There is urgent need for standardized and evidence-based measures contributing to patient safety across
sectorial interfaces of drug therapy. Our findings provide useful orientation for the targeted and rational design of such
improvement strategies.
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Table 1 Calculation of study power

















The primary hypothesis for power calculation implied that the mean number
of prescribed drugs per patient would increase during hospital stay. Relying
on preliminary investigations into the distribution pattern of prescriptions at
admission to Essen University Hospital (mean number of prescriptions ± standard
deviation: 7 ± 3) and assuming correlations of r = 0.2 to r = 0.7 between the mean
prescription numbers at admission and discharge, the standard deviation of the
difference between them was deduced to take on values between 3.0 and 4.5.
The difference between the means itself was assumed to be at least 1. Based on
these assumptions the primary hypothesis was tested in varying scenarios using
matched-pair signed-rank test with a significance level of 5%. With a set sample
size of n = 180 a study power of more than 80% was achieved in each tested
scenario. To account for a drop-out rate of up to 10% the needed number of
participants was determined to be 200.
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Transitions between different levels of healthcare, such
as hospital admission and discharge, pose a considerable
threat to the quality and continuity of drug therapy. This
is primarily due to poor management and transfer of in-
formation both between health professionals and in rela-
tion to their patients [1,2]. These shortcomings gain
significance as increasingly complex medication regi-
mens tend to be under fragmented control of various
specialized caregivers with limited resources for coordin-
ation and documentation of treatment plans. Moreover,
differing drug formularies as well as unsteady and vul-
nerable patient conditions are typical phenomena at care
interfaces that further add to the challenge. In line with this,
a prospective, observational cohort study from Denmark
has found medication data retrieved from the patient, the
general practitioner and the hospital to show complete
consistency for only 8% (95% CI: 3%-17%) of consecutive
medical cases throughout the continuum of care [3].
Despite the aforementioned problems, a hospital stay
allows for intensive medical assessment and monitoring,
thus providing an opportunity to adjust and coordinate all
medication-related aspects for the benefit of cross-sectorial
patient safety. With a view to determining to what ex-
tent current hospital practice lives up to this potential,
the present study explores the role of hospitalization
in prescribing error exposure and medication-related
communication as patients transition from and back
to ambulatory care. This may consequently assist in
informing the rational development of targeted im-
provement strategies.Methods
This exploratory study took place at Essen University
Hospital, a large urban academic medical centre in
Germany, after approval had been granted by the institu-
tion’s ethics review committeea. In accordance with pre-
liminary power calculations (Table 1) we recruited 200
patients from a sample of medical and orthopaedic/sur-
gical wards between mid-June and mid-October 2011.
Due to time constraints it was not possible to visit all of
the wards on a daily basis. However, for each visited
ward recruitment was conducted consecutively accord-
ing to the patients’ order of admission on that given day,
as long as exigencies of clinical routine care would not
stand in the way. Considered for inclusion were patients
aged 18 years or older, being treated with at least one
previously prescribed drug at the time of admission and
giving informed consent to participate in the study.
Transfers from and/or to other institutional health care
facilities were excluded. Only one hospitalization was
taken into account for each individual study participant,
irrespective of any subsequent readmissions.Data collection
Prospective data collection comprised systematic and in-
tegrative collation of comprehensive medication profiles
across the transitions to and from hospital including cor-
responding patient and morbidity characteristics. Fol-
lowing a standardized protocolb, we initially obtained
best-possible home medication histories by interviewing
patients, their families and/or carers. Medication plans
and/or supplies carried by the interviewees were also
taken into account. In addition, we sought any existing
referral letters from community care physicians as well
as routine admission notes and other relevant medical
records from present or past hospitalizations. Hospital
laboratory test results required for prescribing safety ap-
praisal (e.g. MDRD estimates of glomerular filtration
rates [4]) were accessed electronically. On a regular
basis, we contacted health professionals involved in the
ambulatory care of study participants in order to resolve
perceived gaps or inconsistencies in collected informa-
tion. Finally, we retrieved electronic copies of the dis-
charge summaries including recommendations on how
to resume outpatient drug therapy.
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Assisted by a commercial clinical decision support soft-
warec, a clinical pharmacist comparatively reviewed indi-
vidual pre-admission and discharge medication regimens
(including all systemically active drugs for acute or
chronic, regular or pro re nata use under medical control).
This evaluation targeted the following clinically relevant
categories of potentially inadequate prescribing that had
been pre-defined drawing from an evidence-based range
of explicit and implicit assessment criteria [5].
 Inappropriate dosing (e.g. with respect to impaired
kidney function)
 Adverse or redundant combination of drugs
 Contraindicated drug choice
 Unjustified omission of an indicated drug
 Medication without indication
 Inappropriate drug choice for the therapeutic goal
 Medication for a patient aged 65 or older which is
acknowledged as potentially inappropriate in this
age group [6]
 Prescription of inappropriate tablet fractions
Each drug prescribed to a given patient could be pos-
sibly associated with more than one kind of inadequacy
simultaneously. In case of potential uncertainties of clas-
sification consensus between the study authors was
sought.
Moreover, for each study participant the number of
discrepancies between pre-admission and discharge
medication (i.e. temporary or permanent introduction or
withdrawal of a drug, alteration of dose and/or fre-
quency including switching between regular and pro reFigure 1 Results of patient recruitment. Reasons for patient exclusion and
surgical departments.nata application schemes, therapeutic drug substitu-
tions) was determined. It was established to which ex-
tent such medication changes as well as potentially
inappropriate prescribing decisions (see categorization
above) originating from hospital care were communi-
cated in the discharge letter.Statistical analysis
95% confidence intervals were calculated according to
Clopper-Pearson assuming binomial distributions.
Gender allocation of the study sample was tested for
agreement between observed and hypothesized binary
probability. Depending on the scale of measure, the
following tests were used for longitudinal comparisons
of patient characteristics and prescribing error expos-
ure at admission versus discharge: McNemar’s test for
dichotomous variables, Marginal Homogeneity test
for multinomial criteria and Wilcoxon matched-pair
signed-rank test for metric parameters. To identify
risk factors for potentially inadequate prescribing as a
result of hospitalization, binary logistic regression
analyses were conducted using a stepwise approach.
In all adopted statistical procedures a significance
level of α = 0.05 was applied.Results
Out of 200 recruited patients, 187 (93.5%) are included
in the evaluation while the remaining 13 (6.5%) are lost
to follow-up (Figure 1). The majority of exclusions af-
fecting on average 1 in 18 (5.6%) discharged study par-
ticipants is due to missing discharge letters.distribution of included patients to the different medical and
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The study population comprises both genders in com-
parable proportions (47.6% [95% CI: 40.3%-55.0%]
women vs. 52.4% [95% CI: 45.0%-59.7%] men; p = 0.559).
Both at admission and discharge two out of five patients
(38.0% [95% CI: 31.0%-45.3%] vs. 42.2% [95% CI: 35.1%-
49.7%]; p = 0.077) suffer from impaired kidney function
(GFR < 60 ml/min/1.73 m2). More than one third (36.9%)
of the participants is 65 years of age or older. Throughout
the hospital stay a statistically significant increase of pa-
tients with more than 5 prescribed drugs is observed
(52.9% [95% CI: 45.5%-60.3%] vs. 59.9% [95% CI: 52.5%-
67.0%]; p = 0.043).
Influence of hospitalization on prescribing safety across
the care continuum
Only 1 out of 19 (5.3%) patients receives the same medi-
cation regimen both before entering and upon leaving
the hospital. The predominant rest of the patients is ex-
posed to differences between pre-admission and dis-
charge prescriptions occurring at a rate of 461 per 100
hospitalizations. Nearly 9 out of 10 (89.3%) affected pa-
tients encounter multiple (up to 14) medication changes.
However, these extensive modifications in drug ther-
apy apparently do not have an effect on overall prescrib-
ing safety (Table 2). Before admission and at discharge
alike, nearly two thirds of study patients suffer from po-
tentially inadequate prescribing, respectively. Similarly,
the total number of potential prescribing errors per pa-
tient does not change significantly, either.
However, an in-depth analysis of the error pattern that
patients are exposed to reveals significant alterations as-
sociated with hospitalization (Figure 2). Clinically rele-
vant drug-drug interactions as well as omissions of
indicated medication affect more patients at discharge
than at admission. In contrast, merely the relatively
small frequency of patients with redundant prescriptions
is further reduced during inpatient treatment. Mean-
while, patient exposure to other, more prevalent types of
potentially inadequate prescribing such as dosing errors
are not altered significantly between admission and dis-
charge. For instance, at both points in time almost a
quarter of patients with impaired kidney function lacksTable 2 Overall burden of potentially inadequate
prescribing at hospital admission and discharge
Parameter Admission Discharge p-value
Median (IQR) of potential prescribing
errors per patient
1 (0–2) 1 (0–3) 0.135
Number of patients with prescribing
error exposure
118 122 0.651
single error 44 44
0.454
multiple errors 74 78
IQR: interquartile range.appropriate dose adjustment for one or more drugs
(Figure 3).
Two independent risk factors that predispose to the
occurrence of potentially inadequate prescribing as an
outcome of hospital care are shown in Table 3. The
probability of error exposure rises with an increasing
number of prescribed drugs per patient, and individuals
treated on a surgical ward are four times more likely to
be discharged with a prescribing-related safety hazard
than their counterparts from medical departments.
Finally, medication-related communication in the dis-
charge letters of the study population has been found to
be highly incomplete in that only 1 out of 7 (14.8%) al-
terations to the pre-admission medication regimen and
none of the potentially inappropriate prescribing deci-
sions made during inpatient treatment are pointed out
or justified even though the latter occur at a rate of 91
per 100 hospitalizations.
Discussion
In line with findings of an investigation conducted in
Northern Ireland [7], the present study reveals no statis-
tically significant improvement in overall prescribing
safety as a result of routine inpatient treatment even
though a large potential for error reduction is apparent
throughout the care continuum. While the total extent
of potentially inadequate prescribing is shown to remain
constant between admission and discharge, our analyses
convey marked alterations in the pattern of patient-level
error exposure, thereby expanding the evidence pub-
lished so far. For example, the prevalence of patients
whose medication regimen lacks at least one indicated
drug increases significantly by eight per cent until the
end of the hospital stay. In nearly one out of four dis-
charge prescriptions such an unjustified omission has
been identified. Similarly, in their assessment of dis-
charge summaries from an internal medicine department
within a Swiss teaching hospital Perren and colleagues
have found over a quarter of patients to be affected by
this type of prescribing error [8].
Our findings further reveal that surgical patients are
four times more likely to be discharged with potentially
inadequate prescriptions than their counterparts from
medical wards. This independent risk factor might re-
flect that surgical hospitalizations are primarily focused
on acute interventions as opposed to the on-going phar-
macotherapeutic management of comorbidities. This
can be particularly problematic as surgery and follow-
up care themselves regularly require (temporary) modi-
fication and/or expansion of usual home medication
with additional implications for prescribing safety. In
this regard, Boeker and colleagues note that the relative
risk for post-operative complications is elevated almost
by factor three (2.7; 95% CI: 1.8-4.0) in those patients
Figure 2 Number of patients affected by specific types of potentially inadequate prescribing at admission (blue bars) versus discharge (purple
bars). *: p < 0.05; **: p < 0.01.
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treatment [9].
Our findings also confirm that medication-related in-
formation included in discharge letters of study partici-
pants is insufficient to ensure safety and continuity of
drug therapy across different care settings. Identified
shortcomings in communication concern both medica-
tion changes [10,11] and, as this study has additionally
revealed, potentially inadequate prescribing decisions.
Importantly, this impairs the ability of ambulatory care
professionals to provide for an appropriate continuation
of post-hospital drug treatment and latently facilitatesFigure 3 Percentage of renally impaired patients lacking appropriate dose
confidence intervals.occurrence and perpetuation of secondary prescribing
errors [12]. Consequentially, these inadequacies are in
stark contrast to community care providers’ informa-
tional demands as reported in the literature. For ex-
ample, almost nine out of ten general practitioners
anonymously responding to a survey in the catchment
area of a Dutch urban teaching hospital wish to know
whether and why inpatient medication changes have
been introduced, and also appreciate clinical advice per-
taining to prescribing safety [13].
Our study has a number of limitations. Representative-
ness and generalizability of our findings are limited byadjustment at admission versus discharge. Error bars: 95%
Table 3 Binary logistic regression analysis
Variable Univariate analysis Multivariate analysis
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Gender
male 1.959 (1.064-3.608) 0.031 2.115 (0.970-4.611) 0.060
female (reference) − − − −
Age (years) at discharge 1.043 (1.022-1.064) <0.001 1.017 (0.988-1.047) 0.258
GFR (ml/min/1.73 m2) at discharge 0.973 (0.958-0.988) 0.001 1.000 (0.978-1.023) 0.988
Prescribed drugs per patient at discharge 1.551 (1.355-1.777) < 0.001 1.524 (1.297-1.790) < 0.001
Length of stay (days) 1.044 (0.988-1.104) 0.122 0.980 (0.902-1.064) 0.631
Department
surgical 2.353 (0.840-6.594) 0.104 4.069 (1.126-14.703) 0.032
medical (reference) − − − −
(Incremental) impact of selected patient and treatment factors on the probability of exposure to potentially inadequate prescribing associated with hospitalization
(CI: confidence interval).
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like ours tend to have more advanced healthcare needs
than inpatients in general, which will likely affect the
complexity of prescribing patterns and by extension may
result in increased manifestation of related inadequacies
[14]. There are also limiting implications of our study
being monocentric, which may have been mitigated to
only some extent by the broad range and diversity of pa-
tient cases recruited from various medical and surgical
disciplines regardless of any morbidity specific restric-
tions. Meanwhile, patient recruitment has been compro-
mised by the time and effort required for collecting
scientifically sound data in an environment of clinical
routine practice. Thus, it has not been possible to ap-
proach each and every admitted patient for inclusion in
the study. We believe, however, that this has not led to a
systematic distortion of our findings because on each oc-
casion any given study ward was visited patients were re-
cruited consecutively in their order of admission. Finally,
our approach to pre-define targeted categories of inad-
equate prescribing, while lending itself to computational
operationalization of measurement and enhancing ob-
jectivity and reproducibility of obtained results, will not
be able to account for each and every form of insuffi-
cient prescribing safety despite the context sensitivity of
the assessment criteria applied. However, this limitation
may be deemed acceptable in the light of observations
made by a systematic review of the medication error lit-
erature challenging the assumption of an automatically
given association between the number of error types
considered on the one hand and the overall error preva-
lence detected on the other [15].
Conclusions
Our findings highlight the urgent requirement to de-
velop and implement standardized and evidence-basedmeasures contributing to patient safety across sectorial
interfaces of drug therapy. At admission, a best-possible
medication history matching drugs and corresponding
diagnoses should routinely be obtained and made cen-
trally available in order to review quality and coherence
of the underlying prescribing decisions with regard to
the current healthcare needs of the individual patient.
This may subsequently inform inter-professional coord-
ination of further inpatient medication management,
paying particular attention to poly-medicated and/or
surgically treated patients as a possible means to ration-
alize improvement efforts. At discharge, detailed recom-
mendations for continued drug treatment including
insights on medication changes and/or prescribing-
related safety hazards possibly requiring special follow-
up monitoring ought to be transmitted to subsequent
health care providers through appropriate means of
communication. Given restrictions in time and staff re-
sources, the intelligent use of IT solutions holds promise
to support and control implementation of the aforemen-
tioned approaches for the benefit of trans-sectorial pre-
scribing safety.
Endnotes
aCommittee of the Medical Faculty of the University of
Duisburg-Essen
bThe standardized protocol was based on a structured
data collection form detailing demographic, clinical and
medication-related information required for each patient
from pre-admission through to discharge. Conceptual
development of this tool relied on a comprehensive re-
view of the pertinent literature and of outputs from pub-
licly advocated initiatives pursuing seamless medication
safety (e.g. resources from the Safer Healthcare Now!
campaign, the Institute for Healthcare Improvement, the
Agency for Healthcare Research and Quality, etc.). Prior
Klüchtzner and Grandt BMC Health Services Research  (2015) 15:197 Page 7 of 7to implementation in this study, practicability and func-
tionality of the resulting procedure were tested and re-
fined following a stepwise approach in a sample of 100
patients.
cThe tool used is a component of the software product
RpDoc® (version 2.4.2) and as such provides informa-
tional support for medication prescribing and review
with a particular focus on dosing, interactions and re-
dundancies, contraindications and galenical issues (e.g.
breakability of tablets). The user is automatically alerted
to potential prescribing errors of clinical relevance and
can access evidence-based explanations and recommen-
dations for optimized use of each drug. All information
provided is tailored to the specific therapeutic context
by accounting for individual patient and morbidity re-
lated characteristics (e.g. age, sex, body weight, lab re-
sults, indications). The mentioned functionalities are
based on regularly updated databases comprising con-
tents extracted from the summaries of product charac-
teristics, publications from regulatory and other
healthcare related authorities, guidelines from medical
and pharmaceutical associations and societies or their
respective drug commissions, etc.
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